The importance of determining procalcitonin and C reactive protein in different stages of sepsis

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 1, 2010, Pages 60-64

  Baruti Gafurri, Zana ^a   Paçarizi, Hidajet ^a   Zhubi, Bukurije ^b   Begolli, Luljeta ^a   Topçiul, Valdete ^a  

^a UNIVERSITY OF PRISHTINA   (Serbia)

^b Prishtina (NBTCK)   (Greece)

Author keywords

C reactive protein (CRP); Infection; Procalcitonin (PCT); Sepsis; Septic shock

Indexed keywords

EID: 77949417497     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2737     Document Type: Article

References (27)

1. Pepys M.B., Berger A. The renaissance of C reactive protein. BMJ. 2001;322:4-5.
2. Le Molluec J.M., Jullienne A., Chenais J., et al. The complete sequence of human preprocalcitonin. FEBS. 1984; 167: 93-97.
3. Floriańczyk B. Structure and diagnostic value of procalcitonin. Ann. Univ. Mariae Curie Sklodowska Med. 2003;58(i):338-342.
4. Simon L., Saint-Louis P., Amre DK., et al. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediater. Crit. Care Med. 2008;9(4):407-413.
5. Gerard Y., Hober D., Petitjean S., et al High serum procalcitonin level in a 4-year old liver transplant recipient with a disseminated candidiasis. J. Infection. 1995;23:310-311.
6. Beaune G., Bienvenu F., Pondarre Cmonneret G., et al. Serum procalcitonin rise is only slight in two cases of disseminated as-pergillosis. J. Infection. 1998; 26:168-169.
7. Assicot M., Genderel D., Carsin H., Raymond J., et al. High serum procalcitonin concentrations in patients with sepsis and infections. Lancet. 1993; 341: 515-518.
8. Jacobs J.W., Lund P.K., Potts J.T., et al. Procalcitonin is a glycoprotein. J. Biol. Chem. 1981; 256:2803-2807.
9. Bertagna X.Y., Nicholson W.E., Pettengill O.S., et al. Ectopic production of high olecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors. J. Clin. Endocrinol. Metab. 1978; 47:1390-1393.
10. Bernard G.R.,Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protin C for severe sepsis. N. Engl. J. Med. 2001; 344: 699-709.
11. Thiemermann Ch., et al. Nitric oxide and septic shock. General Pharmacology: The vascular system. 1997;29:159-166.
12. Klein J., Marcy SM. Bacterial infections. In: Remington X, Klein X (eds). Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders.1976;785.
13. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-α and interleukin- 1β for early diagnosis of neonatal sepsis. Acta Paed. 1999;88(6):647-650.
14. Muller B., Becker K.L., Schachinger H., et al. Calcitonin precursor are reliable markers of sepsis un a medical intensive care unit. Crit. Care Med. 2000; 28 : 977-983.
15. Nylen E.S., O Neil W., Jordan M.H., et al. Serum procalcitonin as an index of inhalation injury in burns. Horm. Metab. Res. 1992; 24 : 439-443.
16. Whang K.T., Steinwald P.M., White J.C., et al. Serum calcitonin precursor in sepsis and systemic inflammation. J. Clin. Endocri-nol. Metab. 1998; 83: 3296-3301.
17. Hergert M., Lestin H.G., Scherkus M., et al. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 1998; 44: 659-670.
18. Taehler M., Úberfuhr P.,Reichart B., et al. Diferentialdiagnostik der bstossungsrektion und Infektion bei harztransplantierten Patienten: neue Wege mit ytokinen und Procalcitonin als Marker. Transplantationsmedizin. 1997; 9: 44-50.
19. Jaye D.L., Waites K.B. Clinical applications of C-reactive protein in pediatrics. Pediater. Infect. Dis. J. 1997; 16: 735-747.
20. Rivers E., Nguyen B., Havstad S.,et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 2001; 345: 1368-1377.
21. Gramm H.J., Hannemann L. Activity markers for the inflamatory host response and early criteria of sepsis. Clin. Intens. Care. 1996; 7(1): 1-3.
22. Rau B., Steinbach G., Gansauge F., et al The role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1977; 41: 832-840.
23. Reith H.B., Mittelkotter U., Debus ES., et al. Procalcitonin (PCT) imunreactivity in criticaly ill patients on a surgical ICU. The immune Consequences of Trauma, Shock and Sepsis, Edit Mon-duzzi Editore, Bologna. 1997; 1: 675-676.
24. Brunkhorst F.M., Eberhard O.K., Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit. Care Med. 1999; 27: 2172-2176.
25. Ugarte H., Silva E., Mercan D., et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit. Care Med. 1999; 27: 498-504.
26. Matson A., Soni N., Sheldon. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth. Intensive Care. 1991, 19:182-186.
27. Povoa P., Almeida E., Moreira P.,et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998, 24:1052-1056.